Back to results
US 6,403,632 B1Granted
Lactam metalloprotease inhibitors
OwnerJingwu Duan, Carl P. Decicco +2inventors
InventorsJingwu Duan, Carl P. Decicco, Zelda R. Wasserman, Thomas P. Maduskuie, Jr.
Life of this patent
Estimating the term…
Abstract
The present application describes novel lactams and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
Claims18
A compound of formula I:
- or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein;
- A is selected from COR5, —CO2H, CH2CO2H, —CO2R6, —CONHOH, —CONHOR5, —CONHOR6, —NHRa, —N(OH)COR5, —SH, —CH2SH, —SO2NHRa, SN2H2Ra, PO(OH)2, and PO(OH)NHRa;
- ring B is a 5 membered cyclic amide containing 0-1 additional carbonyl groups and 0-1 double bonds;
- R1 is U—X—Y—Z—Ua—Xa—Ya—Za;
- U is absent or is selected from:
- O, NRa, C(O), C(O)O, OC(O), C(O)NRa, NRaC(O), OC(O)O, OC(O)NRa, NRaC(O)O, NRaC(O)NRa, S(O)p, S(O)pNRa, NRaS(O)p, and NRaSO2NRa;
- X is absent or selected from C1-10 alkylene, C2-10 alkenylene, and C2-10 alkynylene;
- Y is absent or selected from O, NRa, S(O)p, and C(O);
- Z is selected from a C3-13 carbocyclic residue substituted with 0-5 Rb and a 5-14 membered heterocyclic system containing from 1-4 heteroatoms selected from the group consisting of N, O, and S and substituted with 0-5 Rb;
- Ua is absent or is selected from:
- O, NRa, C(O), C(O)O, OC(O), C(O)NRa, NRaC(O), OC(O)O, OC(O)NRa, NRaC(O)O, NRaC(O)NRa, S(O)p, S(O)pNRa, NRaS(O)p, and NRaSO2NRa;
- Xa is absent or selected from C1-10 alkylene, C2-10 alkenylene, C2-10 alkynylene;
- Ya is absent or selected from O, NRa, S(O)p, and C(O);
- Za is selected from H, a C3-13 carbocyclic residue substituted with 0-5 Rc and a 5-14 membered heterocyclic system containing from 1-4 heteroatoms selected from the group consisting of N, O, and S and substituted with 0-5 Rc;
- provided that one of Z and Za is a heterocycle and Za is other than quinolinyl;
- R2 is selected from H, Q′, C1-10 alkylene-Q′, C2-10 alkenylene-Q′, C2-10 alkynylene-Q′, (CRR′)r′O(CRR′)r—Q′, (CRR′)r′NRa(CRR′)r—Q′, (CRR′)r′NRaC(O)(CRR′)r—Q′, (CRR′)r′C(O)NRa(CRR′)r—Q′, (CRR′)r′C(O)(CRR′)r—Q′, (CRR′)r′C(O)O(CRR′)r—Q′, (CRR′)r′S(O)p(CRR′)r—Q′, (CRR′)r′SO2NRa(CRR′)r—Q′, (CRR′)r′NRaC(O)NRa(CRR′)r—Q′, (CRR′)r′OC(O)NRa(CRR′)r—Q′, and (CRR′)r′NRaC(O)O(CRR′)r—Q′;
- R, at each occurrence, is independently selected from H, CH3, CH2CH3, CH═CH2, CH═CHCH3, and CH2CH═CH2;
- R′, at each occurrence, is independently selected from H, CH3, CH2CH3, and CH(CH3)2;
- Q′ is selected from H and a C3-13 carbocyclic residue substituted with 0-5 Rb;
- R3 is selected from H, Q, C1-10 alkylene-Q, C2-10 alkenylene-Q, C2-10 alkynylene-Q, (CRR′)r′O(CRR′)r—Q, (CRR′)r′NRa(CRR′)r—Q, (CRR′)rC(O)(CRR′)r—Q, (CRR′)rC(O)O(CRR′)rQ, (CRR′)r′OC(O) (CRR′)r—Q, (CRR′)rC(O)NRa(CRR′)r—Q, (CRR′)r′NRaC(O) (CRR′)r—Q, (CRR′)r′OC(O)O(CRR′)r—Q, (CRR′)r′OC(O)NRa(CRR′)r—Q, (CRR′)r′NRaC(O)O(CRR′)r—Q, (CRR′)r′NRaC(O)NRa(CRR′)r—Q, (CRR′)r′S(O)p(CRR′)r—Q, (CRR′)r′SO2NRa(CRR′)r—Q, (CRR′)r′NRaSO2(CRR′)r—Q, (CRR′)r′NRaSO2NRa(CRR′)r—Q, (CRR′)r′NRaC(O) (CRR′)r″NHQ, (CRR′)r′NRaC(O)(CRR′)rNHC(O)ORa, and (CRR′)r′NRaC(O) (CRR′)rNHC(O) (CRR′)rNHC(O)ORa;
- Q is selected from H and a C3-13 carbocyclic residue substituted with 0-5 Rb;
- R4 is selected from H, C1-10 alkylene-H, C2-10 alkenylene-H, C2-10 alkynylene-H, (CRR′)r′O(CRR′)r—H, (CRR′)r′NRa(CRR′)r—H, (CRR′)r′C(O) (CRR′)r—H, (CRR′)r′C(O)O(CRR′)r—H, (CRR′)r′OC(O)(CRR′)r—H, (CRR′)r′C(O)NRa(CRR′)r—H, (CRR′)r′NRaC(O) (CRR′)r—H, (CRR′)r′OC(O)O(CRR′)r—H, (CRR′)r′OC(O)NRa(CRR′)r—H, (CRR′)r′NRaC(O)O(CRR′)r—H, (CRR′)r′NRaC(O)NRa(CRR′)r—H, (CRR′)r′S(O)p(CRR′)r—H, (CRR′)r′SO2NRa(CRR′)r—H, (CRR′)r′NRaSO2(CRR′)r—H, and (CRR′)r′NRaSO2NRa(CRR′)r—H;
- alternatively, R3 and R4 combine to form a C3-13 carbocyclic residue substituted with R1′ and 0-3 Rb;
- Ra, at each occurrence, is independently selected from H, C1-4 alkyl, phenyl and benzyl;
- Ra′, at each occurrence, is independently selected from H, C1-4 alkyl, phenyl and benzyl;
- Ra″, at each occurrence, is independently selected from H, C1-4 alkyl, benzyl, C3-7 carbocyclic residue, or a 5 to 6 membered heteroaromatic ring containing 1-4 heteroatoms selected from the group consisting of N, O, and S;
- alternatively, Ra and Ra′ taken together with the nitrogen to which they are attached form a 5 or 6 membered ring containing from 0-1 additional heteroatoms selected from the group consisting of N, O, and S;
- Rb, at each occurrence, is independently selected from C1-6 alkyl, ORa, Cl, F, Br, I, ═O, CN, NO2, NRaRa′, C(O)Ra″, C(O)ORa, C(O)NRaRa′, S(O)2NRaRa′, S(O)pRa, CF3, and CF2CF3;
- Rc, at each occurrence, is independently selected from C1-6 alkyl, ORa, Cl, F, Br, I, ═O, CN, NO2, NRaRa′, C(O)Ra, C(O)ORa, C(O)NRaRa′, NRaC(O)NRaRa′, S(O)2NRaRa′, S(O)pRa, CF3, CF2CF3, —CH(═NOH), —C(═NOH)CH3, (CRR′)sO(CRR′)s′Rd, (CRR′)sS(O)p(CRR′)s′Rd, (CRR′)sNRa(CRR′)s′Rd, phenyl, and a 5-14 membered heterocyclic system containing from 1-4 heteroatoms selected from the group consisting of N, O, and S;
- R5, at each occurrence, is selected from C1-10 alkyl substituted with 0-2 Rb, and C1-8 alkyl substituted with 0-2 Rd;
- Rd, at each occurrence, is independently selected from phenyl substituted with 0-3 Rb, biphenyl substituted with 0-2 Rb, and naphthyl substituted with 0-3 Rb;
- R6, at each occurrence, is selected from phenyl, naphthyl, C1-10 alkyl-phenyl-C1-6 alkyl-, C3-11 cycloalkyl, C1-6 alkylcarbonyloxy-C1-3 alkyl-, C1-6 alkoxycarbonyloxy-C1-3 alkyl-, C2-10 alkoxycarbonyl, C3-6 cycloalkylcarbonyloxy-C1-3 alkyl-, C3-6 cycloalkoxycarbonyloxy-C1-3 alkyl-, C3-6 cycloalkoxycarbonyl, phenoxycarbonyl, phenyloxycarbonyloxy-C1-3 alkyl-, phenylcarbonyloxy-C1-3 alkyl-, C1-6 alkoxy-C1-6 alkylcarbonyloxy-C1-3 alkyl-, —C1-10 alkyl-NR7R7a, —CH(R8)OC(═O)R9, and, —CH(R8)OC (═O)OR9;
- R7 is selected from H and C1-10 alkyl, C2-6 alkenyl, C3-6 cycloalkyl-C1-3 alkyl-, and phenyl-C1-6 alkyl-;
- R7a is selected from H and C1-10 alkyl, C2-6 alkenyl, C3-6 cycloalkyl-C1-3 alkyl-, and phenyl-C1-6 alkyl-;
- R8 is selected from H and C1-4 linear alkyl;
- R9 is selected from H, C1-8 alkyl substituted with 1-2 Re, C3-8 cycloalkyl substituted with 1-2 Re, and phenyl substituted with 0-2 Rb;
- Re, at each occurrence, is selected from C1-4 alkyl, C3-8 cycloalkyl, C1-5 alkoxy, phenyl substituted with 0-2 Rb;
- p, at each occurrence, is selected from 0, 1, and 2;
- r, at each occurrence, is selected from 0, 1, 2, 3, 4, and 5;
- r′, at each occurrence, is selected from 0, 1, 2, 3, 4, and 5;
- r″, at each occurrence, is selected from 1, 2, and 3;
- s, at each occurrence, is selected from 0, 1, 2 and 3;
- and,
- s′, at each occurrence, is selected from 0, 1, 2, and 3.
41 more elements
Dependencies are inferred from the claim text.